PDF Archive search engine
Last database update: 28 November at 11:44 - Around 76000 files indexed.

Show results per page

Results for «lymphoma»:

Total: 44 results - 0.038 seconds

28th Consensus Conference 100%

근무처(소속과) 28 TH (해당자만 기재) [GU,GY/Lymphoma] 의사면허번호 CONSENSUS CONFERENCE 성명 근무처주소 전화번호 E-mail 내과 평생교육 연수평점 필요 불필요 내과 혈종분과 전문의 연수평점 필요 불필요 평점카드 회원 한국임상암학회 비회원 전문의/Staff 대한항암요법연구회 회원구분 전임의 전공의 간호사 Invitation 한국임상암학회 / 대한항암요법연구회 03186 서울특별시 종로구 새문안로 92 광화문오피시아 2220호 Tel.


ER1031 99%

Discussion 15:00-15:30 Round Table discussion 14:15-14:20 14:20-14:35 14:35-14:40 14:40-14:55 3 15:30-16:00 Coffee Break SESSION VII - Lymphoma:


2016.01.04 08-10-48Reena Nair cv 2016 97%

Analysis of immunophenotype, IgH chain variable Intramural N region genes and chemokine SDF1/CXCR4 interaction in B – Cell Chronic Lymphocytic Leukemia or Small Lymphocytic NonHodgkin’s Lymphoma, an Intramural TMC Grant.


ER1032 92%

Could we use the relevant molecular biomarkers in the practical management of the older patient with diffuse large B-cell lymphoma?


CV FEDERICO Massimo 90%

Coiffier, Lione)  Membro del Progetto Prognostico Internazionale per i Linfomi Follicolari dal 1999 ad oggi Membro dell’International Task Force sulla malattia dell’Hogkin dal 1999 ad oggi Componente del Comitato Direttivo delll’European Lymphoma Institute, Lione Consulente del Registro Tumori di Salerno dal 1996 al 2009 Consulente del Registro Tumori della Libia Orientale di Bengazhi dal 2003 al 2012.


cadbf3312136057a531b5a6a6435c2f1 (1) 89%

Managing the Emotional Rollercoaster 11:00am 11:15am Break/Exhibitor Session 11:15am 12:30pm Concurrent Breakout Sessions Myeloma David Vesole, MD, PhD Lombardi Comprehensive Cancer Center MedStar Georgetown University Hospital Non-Hodgkin Lymphoma (NHL)—High Grade &


55 (4) 88%

Rituximab-CHOP-ESHAP vs CHOP-ESHAP-high-dose therapy vs conventional CHOP chemotherapy in high-intermediate and high-risk aggressive non-Hodgkin's lymphoma.​​Leuk Lymphoma.


Riches CV March 2016 85%

Lee Moffitt Cancer Center, 2010 ASBMT/CIBMTR Travel Grant Award, for abstract “Equivalent Disease Free and Overall Survival in Lymphoma Patients Treated with either Myeloablative or Non-Myeloablative Conditioning and Allogeneic Transplant,” 2006 Clinical Excellence Award, Department of Medicine, University of Minnesota, 2007 Searle/Pharmacia Fellow in Hematology/Oncology, Northwestern University, 2000 Outstanding Fourth Year Student for Scholarship and Humanism in Internal Medicine University of Kentucky Department of Medicine, 1997 BIBLIOGRAPHY AND PRODUCTS OF SCHOLARSHIP Book Chapters 1.


2534 - MD Anderson Cancer Center Madrid- Pathology Meeting - program 76%

Gynecologic tumors 10:15 - 10:45 What’s new in T-cell lymphomas and Hodgkin lymphoma Moderator:


2017DBS Antibody Flyer 102017 web 75%

WT1 Fascin-1 Fascin-1 is a sensitive marker for Reed-Sternberg cells of Hodgkin's Disease and a helpful marker to distinguish between Hodgkin Lymphoma and non-Hodgkin Lymphoma in difficult cases.


Dr-Griesinger Veroeffentlichungen 66%

Hohloch K, Lakhani VJ, SahlmannC, Wulf G, Meller J, Trümper L, Griesinger F Tandem-high dose therapy in relapsed and refractory B-cell lymphoma, Phase II trial of a myeloablative chemotherapy followed by escalated radioimmunotherapy with I131 anti CD20 antibody.


Yas Links Golf Club Make a Wish 64%

Yas Links Golf Club 13 Amani, 9 years old, diagnosed with Lymphoma Cancer Wished for an IPhone 5 14 Salama, 7 years old, diagnosed with Diabetes Type 1 Wished for a MacBook 15 Farouq, 4 years old, diagnosed with Hemophilia Wished for a Laptop Share the Power of a Wish!


Client intake form Inner Harmony 64%

Contact Lenses?_______ Hearing Aids?_______ Dentures?_______ Please Indicate and List Any Medical Problems or Conditions Recent Head Injury -- Stroke, Aneurysm, Cerebral Hemorrhage, other Recent Injury – whiplash, sprain, bruise, other Skin Condition – acne, rash, allergies, skin cancer, other Lymphatic Condition – swollen glands, lymphoma, other Circulatory Condition – heart disease, varicose veins, phlebitis, arteriosclerosis, other Neurological Condition – sciatica, numbness/tingling, stroke, epilepsy, other Back Problems – pain or stiffness, sacroiliac problems, other Joint Problems – pain or stiffness, osteoarthritis, rheumatoid arthritis, other Bone Conditions – osteoporosis, previous fractures, cancer, other Headaches – migraines, PMS, tension, sinus, other Emotional Difficulties – depression, anxiety, other Stress (explain) Previous surgery (type and date Other Current Medications Doctor/Therapist_____________________________________________ Phone _____________________________ You have my permission to contact my health care provider(s) if warranted.


Chemo 63%

20 April 2004 Introduction In adults, cytotoxic chemotherapy became established in the 1970s as a curative treatment in advanced Hodgkin’s disease [1], non-Hodgkin’s lymphoma [2], teratoma of testis [3] and as an adjuvant treatment for early breast cancer [4].


2016 Scholarship Winner Press Release 60%

Lymphoma Society, Autism Speaks, Abi's Place, The Multiple Sclerosis Foundation and more.


Download Swog Fall 2012 Group Meeting PDF 56%

81-85 Lymphoma Committee...........................................................................................................................................16 &


rabbittstaug144 55%

I defined the linkage of antibody and T cell receptor genes with several cancer-specific chromosomal translocations and, by identifying somatic mutations in CMYC (in Burkitt’s lymphoma), provided the first experimental evidence that hypermutation can alter DNA linked to constant regions genes which is the process that diversifies antibody V genes.


310812900-Final-Announcement-ROICAM-4 55%

breast cancer, lung cancer, colorectal cancer, lymphoma, and many more.


The Blood, The Marrow, The Giant Needle 55%

This process is often called rescue (for diseases such as lymphoma and neuroblastoma).


CV 55%


ER1120 54%

22/02/2017 WHO Classification:


ER1054 54%

Zumi the Palliative Pig - Krista Dobbie, MD 12:45 Break/Dessert 1:00 Chronic Lymphocytic Leukemia - Matt Kalaycio, MD 1:35 Indolent or Aggressive Lymphoma - Paolo Caimi, MD 2:05 Break 2:20 Myeloma - David Vesole, MD 2:50 Myelodysplasia - Yogen Saunthararajah, MD 3:20 Wrap Up 3:30 Adjourn Time for questions and answers are included in each presentation.



Neck Cancer Lung Cancer Lymphoma (Including referral details for all suspected haematological malignancies) Skin Cancer Upper Gastrointestinal Cancer Urological Cancer Brain &


JDIT-2016-0712-022 51%

Journal of Diagnostic Imaging in Therapy.